GNA11 and uveal melanoma: The mTOR pathway is one of the many survival pathways activated by pathogenic variants in the GNAQ or GNA11 genes,51 supporting the need for investigations into the efficacy of therapies for uveal melanoma containing mTOR inhibitors.